½ºÅ¸Æ¾°ú Ç×°íÇ÷¾ÐÁ¦ º´¿ë¿ä¹ýÀÇ ½ÉÇ÷°ü ÀÓ»óÇýÅÃÀ» ¸íÈ®È÷ º¸¿©ÁØ ´ëÇ¥Àû »ç·Ê·Î´Â ¹«ÀÛÀ§·´ëÁ¶±º Àӻ󿬱¸(RCT) HOPE-3µµ »©³õÀ» ¼ö ¾ø´Ù. ASCOT-LLA ¿¬±¸°¡ ½ÉÇ÷°üÁúȯ °íÀ§Ç豺¿¡¼ µÎ Á¦Á¦ÀÇ ÇýÅÃÀ» °ËÁõÇß´Ù¸é HOPE-3 ¿¬±¸´Â ½ÉÇ÷°üÁúȯ Áߵ À§Ç豺¿¡¼ Ç÷¾Ð·ÁöÁúÄ¡·áÀÇ ½ÉÇ÷°ü ÀÓ»óÇýÅÃ, Áï ½ÉÇ÷°üÁúȯ 1Â÷¿¹¹æ È¿°ú¸¦ º¸°íÇß´Ù. Ç×°íÇ÷¾ÐÁ¦ º´¿ë¿ä¹ý Ä¡·á±º¿¡¼´Â À§¾à ´ëºñ ½ÉÇ÷°ü»ç°ÇÀÌ °¨¼ÒÇÏÁö ¾ÊÀº ¹Ý¸é, ¿©±â¿¡ ½ºÅ¸Æ¾ Ä¡·á¸¦ ´õÇÑ °á°ú ½ÉÇ÷°ü»ç°Ç À§ÇèÀÌ À¯ÀÇÇÏ°Ô ÁÙ¾ú´Ù. ¿¬±¸´Â ½ÉÇ÷°üÁúȯÀÌ ¾ø´Â Áߵ À§Ç豺 ȯÀÚµéÀ» ´ë»óÀ¸·Î ÁöÁú(·Î¼ö¹Ù½ºÅ¸Æ¾ 10mg), Ç÷¾Ð(ĵ¥»ç¸£Åº 16mg + È÷µå·ÎŬ·Î·ÎƼ¾ÆÁöµå ÀÌ´¢Á¦ 12.5mg), ÁöÁú·Ç÷¾Ð(·Î¼ö¹Ù½ºÅ¸Æ¾ + ĵ¥»ç¸£Åº + ÀÌ´¢Á¦) Ä¡·áÀÇ ½ÉÇ÷°ü»ç°Ç ¿¹¹æÈ¿°ú¸¦ Æò°¡Çß´Ù. |
HOPE-3
¸ÕÀú ·Î¼ö¹Ù½ºÅ¸Æ¾ 10mg Ä¡·á±º¿¡¼´Â À§¾à±º ´ëºñ ½ÉÇ÷°üÁúȯ À§ÇèÀÌ À¯ÀÇÇÏ°Ô °¨¼ÒÇß´Ù. ¹Ý¸é ĵ¥»ç¸£Åº + ÀÌ´¢Á¦ Ä¡·á±×·ì¿¡¼´Â ½ÉÇ÷°ü»ç°Ç ¹ß»ý·üÀÇ °¨¼ÒÇýÅÃÀÌ °üÂûµÇÁö ¾Ê¾Ò´Ù. ·Î¼ö¹Ù½ºÅ¸Æ¾ + ĵ¥»ç¸£Åº + ÀÌ´¢Á¦ Ä¡·á±ºÀÇ 1Â÷Á¾·áÁ¡(½ÉÇ÷°ü »ç¸Á, ½É±Ù°æ»öÁõ, ³úÁ¹Áß) »ó´ëÀ§Çèµµ´Â À§¾à±º ´ëºñ À¯ÀǹÌÇÏ°Ô ³·¾Ò´Ù.
Ç÷¾ÐÄ¡·á±º
HOPE-3 ¿¬±¸¿¡¼´Â ¼öÃà±âÇ÷¾ÐÀÌ 140mmHg¸¦ ³Ñ¾î°¡¸é ½ÉÇ÷°üÁúȯ À§ÇèµµÀÇ ³ô°í ³·À½¿¡ °ü°è¾øÀÌ Áï½Ã Ç×°íÇ÷¾ÐÁ¦ Ä¡·á¸¦ ½ÃÀÛÇØ¾ß ÇÑ´Ù´Â °ÍÀÌ ÀçÂ÷ °Á¶µÆ´Ù. HOPE-3 ¿¬±¸ÀÇ Ç÷¾ÐÄ¡·á±º ºÐ¼®°á°ú·Î, ½ÉÇ÷°üÁúȯ ¹«º´·ÂÀÇ Áߵ À§Ç豺 ȯÀÚ¸¦ ´ë»óÀ¸·Î Á¶±â¿¡ Ç×°íÇ÷¾ÐÁ¦ Ä¡·á¸¦ Àû¿ëÇÑ °á°ú ±âÀú½ÃÁ¡ÀÇ Ç÷¾ÐÀÌ °íÇ÷¾Ð °æ°èÄ¡¸¦ ³Ñ´Â ȯÀÚ±×·ì¿¡¼ ½ÉÇ÷°üÁúȯ 1Â÷¿¹¹æ È¿°ú°¡ ¿ì¼öÇÑ °ÍÀ¸·Î ³ªÅ¸³µ´Ù.
ĵ¥»ç¸£Åº + ÀÌ´¢Á¦ Àü·«À» À§¾à°ú ºñ±³·Æò°¡ÇÑ HOPE-3 Ç÷¾Ð¿¬±¸´Â Àüü ȯÀÚ±º¿¡¼ ½ÉÇ÷°üÁúȯ À§Çè°¨¼ÒÀÇ À¯ÀÇÇÑ Â÷À̸¦ µµÃâÇÏÁö´Â ¸øÇß´Ù. ÇÏÁö¸¸ ±âÀú½ÃÁ¡(baseline)ÀÇ ¼öÃà±âÇ÷¾Ð ¼öÄ¡¿¡ µû¶ó ½ÉÇ÷°üÁúȯ À§Çè°¨¼Ò ÇýÅÃÀÌ Àְųª ¾ø´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù. °íÇ÷¾Ð °æ°èÄ¡¸¦ ³Ñ¾î¼± ȯÀÚ±×·ì¿¡¼´Â Ç×°íÇ÷¾ÐÁ¦ Ä¡·áÀÇ ½ÉÇ÷°ü ÀÓ»óÇýÅÃÀÌ È®ÀÎµÈ °Í.
HOPE-3 Ç÷¾Ð¿¬±¸´Â ½ÉÇ÷°üÁúȯÀÌ ¾ø´Â Áߵ À§Ç豺 ȯÀÚ¸¦ ´ë»óÀ¸·Î Ç÷¾Ð°Çϸ¦ ÅëÇÑ ½ÉÇ÷°üÁúȯ À§Çè°¨¼Ò È¿°ú¸¦ Æò°¡°íÀÚ Çß´Ù. ½ÉÇ÷°üÁúȯ Áߵ À§Ç豺À̶õ ¿¬°£ ÁÖ¿ä½ÉÇ÷°ü»ç°Ç À§ÇèÀÌ ´ë·« 1% Á¤µµ·Î, Ç÷°üÁúȯÀÌ ¾ø°í ¼öÃà±âÇ÷¾ÐÀÌ 160mmHg ¹Ì¸¸ÀÎ °æ¿ì¸¦ ÁöĪÇÑ´Ù.
ĵ¥»ç¸£Åº + ÀÌ´¢Á¦ ȯÀÚµéÀº ¾ÈÁö¿ÀÅٽżö¿ëüÂ÷´ÜÁ¦(ARB) ĵ¥»ç¸£Åº 16mg + È÷µå·ÎŬ·Î·ÎƼ¾ÆÁöµå(HCTZ) 12.5mg ¶Ç´Â À§¾à±ºÀ¸·Î ¹«ÀÛÀ§ ¹èÁ¤µÅ Ä¡·á·°üÂûÀÌ ÁøÇàµÆ´Ù. 1Â÷ Á¾·áÁ¡Àº ½ÉÇ÷°ü »ç¸Á·ºñÄ¡¸íÀû ½É±Ù°æ»öÁõ·ºñÄ¡¸íÀû ³úÁ¹ÁßÀÇ º¹Çպ󵵸¦, 2Â÷ Á¾·áÁ¡Àº ½ÉÀå¹ßÀÛ ÈÄ ¼Ò»ý·½ÉºÎÀü·Ç÷°üÀçÇü¼º¼úÀ» Ãß°¡ÇØ Æò°¡Çß´Ù.
¼öÃà±âÇ÷¾Ð £¾ 143mmHg
5.6³âÀÇ °üÂû°á°ú, 1Â÷Á¾·áÁ¡Àº ĵ¥»ç¸£Åº±º 4.1% ´ë À§¾à±º 4.4%·Î À¯ÀÇÇÑ Â÷ÀÌ°¡ ¾ø¾ú´Ù(hazard ratio 0.93, P=0.40). 2Â÷Á¾·áÁ¡ ¶ÇÇÑ °¢°¢ 4.9% ´ë 5.2%(hazard ratio 0.95, P=0.51)·Î µ¿ÀÏÇÑ °æÇâÀ» º¸¿´´Ù.
ÇÏÁö¸¸ ±âÀú½ÃÁ¡ÀÇ ¼öÃà±âÇ÷¾Ð ¼öÄ¡¿¡ µû¶ó ÇÏÀ§ºÐ¼®À» ½Ç½ÃÇßÀ» ¶§´Â ´Ù¸¥ ¾ç»óÀÌ ³ªÅ¸³µ´Ù. º£À̽º¶óÀÎ ¼öÃà±âÇ÷¾ÐÀº ³úÁ¹ÁßÀ» Á¦¿ÜÇÑ 1·2Â÷Á¾·áÁ¡ ÀÎÀÚ¿¡ ¸ðµÎ À¯ÀÇÇÑ ¿µÇâÀ» ¹ÌÃÆ´Ù(P=0.009). ±âÀú½ÃÁ¡ ¼öÃà±âÇ÷¾ÐÀÌ 143.5mmHg¸¦ ÃÊ°ú(Æò±Õ 154.1±8.9mmHg)ÇÑ È¯ÀÚ±×·ì¿¡¼´Â À§¾à±º ´ëºñ ĵ¥»ç¸£Åº + HCTZ±ºÀÇ 1Â÷ Á¾·áÁ¡ »ó´ëÀ§Çèµµ°¡ 27% À¯ÀǹÌÇÏ°Ô ³·¾Ò´Ù(4.8% ´ë 6.5%, hazard ratio 0.73, 95% CI 0.56-0.94). 2Â÷ Á¾·áÁ¡ »ó´ëÀ§Çèµµ ¿ª½Ã 24% ³·¾Æ Åë°èÀûÀ¸·Î ÀÇ¹Ì ÀÖ´Â Â÷À̸¦ º¸¿´´Ù(hazard ratio 0.76, 95% CI 0.60-0.96).
ÁöÁúÄ¡·á±º
ÇÑÆí HOPE-3ÀÇ ÁöÁúÄ¡·á ºÐ¼®¿¡¼´Â ´ëÇ¥Àû ½ºÅ¸Æ¾ Á¦Á¦ ·Î¼ö¹Ù½ºÅ¸Æ¾ 10mg ¿ä¹ýÀÇ ½ÉÇ÷°üÁúȯ 1Â÷¿¹¹æ È¿°ú°¡ ³ªÅ¸³µ´Ù. ½ÉÇ÷°ü »ç¸Á, ½É±Ù°æ»öÁõ, ³úÁ¹Áß º¹ÇÕºóµµ´Â ·Î¼ö¹Ù½ºÅ¸Æ¾ 10mg±º 3.7% ´ë À§¾à±º 4.8%·Î ·Î¼ö¹Ù½ºÅ¸Æ¾±ºÀÇ À§Çèµµ°¡ 24% À¯ÀÇÇÏ°Ô ³·¾Ò´Ù(P=0.002).
2Â÷Á¾·áÁ¡(½ÉÇ÷°ü »ç¸Á, ½É±Ù°æ»öÁõ, ³úÁ¹Áß, ½ÉÀå¹ßÀÛ ¼Ò»ý, ½ÉºÎÀü, Àç°ü·ù¼ú)Àº °¢°¢ 4.4% ´ë 5.7%·Î ·Î¼ö¹Ù½ºÅ¸Æ¾±ºÀÇ À§Çèµµ°¡ 25% °¨¼ÒÇß´Ù(P£¼0.001). 2Â÷Á¾·áÁ¡ ¼¼ºÎÆò°¡¿¡¼´Â ½É±Ù°æ»öÁõ 0.7% ´ë 1.1%(P£¾0.05), °ü»óµ¿¸ÆÁúȯ 1.7% ´ë 2.2%(P=0.02), ½ÉÇ÷°ü ¿øÀÎ ÀÔ¿øÀ²Àº 4.4% ´ë 5.8%(P£¼0.001)·Î Â÷À̸¦ º¸¿´´Ù.
Ç÷¾Ð·ÁöÁúÄ¡·á±º
ÇÑÆí ·Î¼ö¹Ù½ºÅ¸Æ¾ + ĵ¥»ç¸£Åº + ÀÌ´¢Á¦ Ä¡·á±º°ú À§¾à±º °£ 1Â÷Á¾·áÁ¡(½ÉÇ÷°ü »ç¸Á, ½É±Ù°æ»öÁõ, ³úÁ¹Áß) ¹ß»ý·üÀº 3.6% ´ë 5%·Î Ç×°íÇ÷¾ÐÁ¦¿Í ½ºÅ¸Æ¾ º´¿ëÄ¡·á±ºÀÇ À§Çèµµ°¡ 29% ³·¾Ò´Ù(hazard ratio 0.71, P=0.005). ¼¼ºÎÆò°¡¿¡¼ ½ÉÇ÷°ü ¿øÀÎ »ç¸ÁÀº 2.4% ´ë 2.9%(P£¾0.05), ³úÁ¹Áß 1% ´ë 1.7%(P£¼0.05), ½É±Ù°æ»öÁõ 0.7% ´ë 1.2%(P£¼0.05), ½ÉÇ÷°ü ¿øÀÎ ÀÔ¿øÀ² 4.4% ´ë 6%(p=0.005)·Î ÀÏ°üµÈ °æÇâÀ» º¸°íÇß´Ù.
ÀÌ¿Í °ü·ÃÇØ Ä³³ª´Ù ¸Æ¸¶½ºÅÍ´ëÇÐ Eva Lonn ±³¼ö´Â “ĵ¥»ç¸£Åº + ÀÌ´¢Á¦ÀÇ Ç×°íÇ÷¾ÐÁ¦ ¿ä¹ýÀÌ ÇýÅÃÀ» º¸ÀÌÁö ¸øÇß´Ù´Â Á¡Àº Ç÷¾Ð°Çϸ¸À¸·Î ½ÉÇ÷°üÁúȯÀ» ¿¹¹æÇϱ⿡ ¿ªºÎÁ·À̶ó´Â Á¡À» º¸¿©ÁÖ¸ç, Ç×°íÇ÷¾ÐÁ¦ º´¿ë¿ä¹ý¿¡ ·Î¼ö¹Ù½ºÅ¸Æ¾À» Ãß°¡ÇßÀ» ¶§ À¯ÀÇÇÑ È¿°ú°¡ ³ªÅ¸³µ´Ù´Â µ¥ ÁÖ¸ñÇØ¾ß ÇÑ´Ù”°í ¸»Çß´Ù. °°Àº ´ëÇÐ Salim Yusuf ±³¼ö´Â “´ëºÎºÐÀÇ °íÇ÷¾Ð °¡À̵å¶óÀÎÀº Ç×°íÇ÷¾ÐÁ¦ÀÇ Á¾·ù³ª Ç÷¾Ð ¸ñǥġ¿¡ ´ëÇØ °Á¶ÇÏ°í ÀÖÁö¸¸, °íÇ÷¾Ð ȯÀÚ Ä¡·á ½Ã ½ºÅ¸Æ¾ÀÇ Á߿伺¿¡ ´ëÇؼ´Â Å©°Ô ¹«°Ô¸¦ µÎ°í ÀÖÁö ¾Ê´Ù”¸ç µÎ ½ÉÇ÷°üÁúȯ À§ÇèÀÎÀÚÀÇ µ¿½Ã°ü¸®¸¦ ÁÖ¹®Çß´Ù.
ÀÌ»óµ· ±âÀÚ sdlee@mostonline.co.kr
<ÀúÀÛ±ÇÀÚ © THE MOST, ¹«´Ü ÀüÀç ¹× Àç¹èÆ÷ ±ÝÁö>
#·Î¼ö¹Ù½ºÅ¸Æ¾#ĵ¥»ç¸£Åº##LDL-C#½ºÅ¸Æ¾#ARB#ASCOT-LLA#HOPE-3